
Hydroxypropyl-betacyclodextrin HPB and HP-Parenteral grade
KLEPTOSE® HPB & HP hydroxypropyl-betacyclodextrin parenteral grade materials that are used as encapsulating agents for Rx injectables. These are modified betacyclodextrins for parenteral use. Modified betacyclodextrins used in parenteral preparations provide active substance stabilization improvement against light and oxidation as well as enhancement of solubilization of active pharmaceutical ingredients.
Molecular encapsulation with modified beta-cyclodextrins has become an accepted and useful tool for pharmaceutical developers. There are currently several pharmaceutical products containing modified cyclodextrin complexes on the market. Roquette has pioneered the industrial development of cyclodextrins with its KLEPTOSE® range of betacyclodextrins.
hydroxypropyl-betacyclodextrin (HPBCD) is a white, amorphous powder. The HPBCD molecule is a torus shaped ring with a polar hydrophilic outside and an apolar hydrophobic cavity.
Applications
-
Injectables
- Rx Injectables
Functional Properties
-
Excipient
- Encapsulating Agent
- Solubilizer
- Stabilizer
Documents & Samples

-
-
Andorra
-
Armenia
-
Austria
-
Azerbaijan
-
Belgium
-
Bulgaria
-
Canary Islands
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
France
-
Georgia
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Moldova
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Russia
-
San Marino
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
Switzerland
-
Turkey
-
Ukraine
-
United Kingdom
-
Vatican City
-
-
-
Canada
-
Mexico
-
United States
-
-
-
Argentina
-
Bolivia
-
Brazil
-
Chile
-
Colombia
-
Ecuador
-
Guyana
-
Paraguay
-
Peru
-
Suriname
-
Uruguay
-
Venezuela
-
-
-
Anguilla
-
Antigua & Barbuda
-
Aruba
-
Barbados
-
Bermuda
-
British Virgin Islands
-
Cayman Islands
-
Costa Rica
-
Guatemala
-
Honduras
-
Nicaragua
-
Panama
-
El Salvador
-
Dominica
-
Dominican Republic
-
Grenada
-
Guadeloupe
-
Haiti
-
Jamaica
-
Martinique
-
Montserrat
-
Saint Lucia
-
Saint Vincent & the Grenadines
-
The Bahamas
-
Trinidad & Tobago
-
Turks & Caicos Islands
-
United States Virgin Islands
-
-
-
Bangladesh
-
Bhutan
-
Brunei
-
Cambodia
-
China
-
Hong Kong (China)
-
India
-
Indonesia
-
Japan
-
Kazakhstan
-
Kyrgyzstan
-
Laos
-
Malaysia
-
Maldives
-
Mongolia
-
Myanmar
-
Nepal
-
Pakistan
-
Philippines
-
Singapore
-
South Korea
-
Sri Lanka
-
Taiwan (China)
-
Tajikistan
-
Thailand
-
Turkmenistan
-
Uzbekistan
-
Vietnam
-
-
-
Australia
-
Federated States of Micronesia
-
Fiji
-
French Polynesia
-
Kiribati
-
Marshall Islands
-
Nauru
-
New Caledonia
-
New Zealand
-
Northern Mariana Islands
-
Palau
-
Pitcairn Islands
-
Samoa
-
Solomon Islands
-
Tonga
-
Tuvalu
-
Vanuatu
-
Wallis and Futuna
-
-
-
Bahrain
-
Palestine
-
Cyprus
-
Iraq
-
Israel
-
Jordan
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
-
-
-
Algeria
-
Angola
-
Benin
-
Botswana
-
Cameroon
-
Cape Verde
-
Chad
-
Comoros
-
Djibouti
-
Eritrea
-
Ethiopia
-
Gabon
-
Ghana
-
Ivory Coast
-
Kenya
-
Lesotho
-
Liberia
-
Madagascar
-
Malawi
-
Mauritania
-
Mauritius
-
Mayotte
-
Morocco
-
Mozambique
-
Namibia
-
Niger
-
Nigeria
-
Réunion
-
Rwanda
-
Saint Helena
-
São Tomé and Principe
-
Senegal
-
Seychelles
-
Sierra Leone
-
South Africa
-
Swaziland
-
Tanzania
-
The Gambia
-
Togo
-
Uganda
-
Zambia
-
Zimbabwe
-
Product Types
KLEPTOSE® HP PARENTERAL GRADE - #346114
High molecular substitution (MS) = 0.81 - 0.99
KLEPTOSE® HPB PARENTERAL GRADE - #346111
Medium molecular substitution (MS) = 0.58 - 0.68
KLEPTOSE® HPB-LB PARENTERAL GRADE - #346115
Medium molecular substitution (MS) = 0.50 - 0.71
Order
Regulation & Compliance
Compliance
- European Pharmacopoeia
- United States Pharmacopeia
Regulatory
• A Drug Master File (DMF) is available. Please contact us to discuss this information
Need more support ?
Help & Support
Related Products
-
KLEPTOSE® HP ORAL GRADE AND HPB ORAL GRADE can be used to provide excipient benefits in many nutraceutical and oral dosage applications.
Key attributes:- High aqueous solubility
- Encapsulation process versatility
- Multi-compendial
-
KLEPTOSE® Betacyclodextrins are efficient solubilizers stabilization enhancers and taste masking agents.
Key attributes:- Direct Compression
- Encapsulation process versatility
- Superior purity
-
NEOSORB® PF is a pyrogen-free sorbitol used for parenteral preparations: API applications and excipient applications.
Key attributes:- Pyrogen Free
- DMF/CEP Available
- GMP Certificate
-
Sodium Gluconate Pharma is a pyrogen-free substance from Roquette that is used for parenteral preparations as well as in Rx injectables.
Key attributes:- Pyrogen Free
- DMF Available
- GMP Certificate
-
LYCADEX® PF Pyrogen-free dextrose monohydrate is a physiological sugar used to provide excipient and API benefits.
Key attributes:- Pyrogen Free
- GMP Certificate
- DMF/CEP Available
-
PEARLITOL® PF is a mannitol pyrogen-free used for parenteral preparations and Rx injectables.
Key attributes:- Pyrogen Free
- DMF/CEP Available
- GMP Certificate
-
KLEPTOSE® LINECAPS Pea maltodextrin provides benefits by acting as a solubilizer stabilizer and taste-making agent
Key attributes:- High aqueous solubility
- Encapsulation process versatility
- Pharmaceutical and nutraceutical
-
LYCAGEL® offers excellent film-forming properties for the manufacture of non-gelatin softgels.
Key attributes:- High productivity
- Plant-based ingredient
-
CLEARGUM® CO Octenyl succinate starches provide excipient benefits by acting as both an emulsifier and a solubilizer.
Key attributes:- Emulsifier
- Solubilizer
-
TACKIDEX® Potato dextrins provide a variety of benefits to the manufacturer and consumer as both an excipient and a nutrient.
Key attributes:- Variety of Delivery Forms
- Filler, Binder or Filler/Binder
- Fibre & Carbohydrate Source